Skip to main content

PRO-10001

NCT02645539

PRO-10001

Principal Investigator

Sponsor

NupulseCV, Inc.

The purpose of this feasibility study is to assess the preliminary safety and clinical performance of the intravascular ventricular assist system (iVAS).  Data obtained from the study will be used to design a future clinical trial suitable for assessing longer-term use in heart failure patients.

This study is currently enrolling.